AM

American Well Corporation

AMWLHealthcareNASDAQ

Health Information Services · Last scanned Jul 22, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$249.3M
-2.0% YoY
Net Income
-$95.7M
+54.0% YoY
EBITDA
-$71.3M
+61.4% YoY
Free Cash Flow
-$11.8M

Scan Results

Daily timeframe
6 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 15 RSI OverboughtRSI 76.4, above 70, stock may be overbought
MACD Positive CrossoverHistogram +0.1668, positive momentum
Jul 14 MACD Positive CrossoverHistogram +0.1218, positive momentum
RSI OverboughtRSI 79.0, above 70, stock may be overbought
About American Well Corporation

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The $208.4M market capitalization puts AMWL squarely in micro-cap range for its industry. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care.

Where AMWL stands vs its 150-day and 200-day moving averages

As of the July 15, 2026 close, AMWL finished 72.97% above its 150-day moving average ($6.29) and 81.94% above its 200-day moving average ($5.98). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is AMWL overbought or oversold?

At the July 15, 2026 close, AMWL's RSI(14) was 76.4, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$208.4M
Fwd P/E-7.42
EPS$-5.38
Beta1.70
52W Change+52.4%
ROE-31.8%
Analysis

With $180.0M in cash and $4.0M in debt, AMWL maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. The company is burning cash, with free cash flow at -$11.8M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Return on equity stands at -31.8%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has pulled back from $277.2M (2022) to $249.3M (2025), a 10% decline worth watching.

American Well Corporation's elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. No single metric tells the full story. Reviewing AMWL's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms
AMWL: American Well Corporation Technical Analysis (200-Day MA, RSI, MACD) | Scanance